59:58
Managing Cancer-Associated Thrombosis
Broadcast Date
Presenter
Agnes Lee, MD, MSc, FRCPC and Marc Carrier, MD, MSc, FRCPC
Therapeutic Area
Cardiovascular
Learning Objectives
- Manage the transition from dual anti-platelet therapy at 12 months post-index event to long term antithrombotic management
- Recognize the myth of the stable CAD patient by demonstrating the rate of recurrent event and mortality over 10 years
- Define therapeutic options for two typical patient scenarios: 12 months post-PCI and chronic secondary prevention
- Summarize different therapeutic options and targets for secondary prevention
